HZNP News and Press, Horizon Therapeutics Public Limited Company From 05/29/23

2023-05-29 05:36:15 ET Summary Amgen's stock has seen a further pullback since it announced an acquisition of Horizon Therapeutics in December. Shares are down by nearly a quarter as the re-rating starts to look interesting with fundamental valuations starting to provide support. ...

2023-05-24 05:15:00 ET The Federal Trade Commission (FTC) has been taking a much more adversarial approach to mergers and acquisitions lately. For instance, it recently said it plans to block the pending deal between pharmaceutical companies Horizon Therapeutics (NASDAQ: HZNP) and ...

2023-05-23 12:38:56 ET The Federal Trade Commission lawsuit to block Amgen's ( NASDAQ: AMGN ) planned purchase of Horizon Therapeutics ( NASDAQ: HZNP ) is set for a hearing on Sept. 11. The trial date was set at a case management hearing in front of U.S. District Judge...

-- Phase 2 results for dazodalibep in Sjögren’s syndrome to be presented on June 1, 11:35-11:45 a.m. CEST and June 3, 9:35-9:45 a.m. CEST -- -- Planned presentations illustrate Horizon’s momentum in raising standards of care for rheumatology conditions inclu...

2023-05-21 07:32:58 ET Summary Shares of antibody therapy concern Viridian Therapeutics, Inc. are off some 40% since setting an all-time high of $39.00 in January following a positive readout on lead candidate VRDN-001. Despite pivotal trial data not due until mid- and late 2024, ...

2023-05-18 09:25:44 ET Amgen ( NASDAQ: AMGN ) agreed not close its $28 billion purchase of Horizon Therapeutics ( NASDAQ: HZNP ) before Sept. 15 or the second business day after the court rules on the Federal Trade Commissions' request to block the deal. Horiz...

2023-05-17 10:42:12 ET Regeneron ( NASDAQ: REGN ) CEO Leonard Schleifer said he agrees with the Federal Trade Commission's lawsuit objecting to Amgen's ( NASDAQ: AMGN ) acquisition of Horizon Therapeutics ( NASDAQ: HZNP ). Speaking at a Financial Times ph...

2023-05-17 10:41:26 ET Horizon Therapeutics ( NASDAQ: HZNP ) rose 3.2% at least partly amid some speculation that Amgen ( NASDAQ: AMGN ) could reach a settlement with the Federal Trade Commission in its suit to block the $28 billion deal. There's an idea that there c...

2023-05-17 05:13:00 ET Deal or no deal? That's now the big question for investors concerning Amgen 's (NASDAQ: AMGN) pending $28 billion acquisition of Horizon Therapeutics (NASDAQ: HZNP) . The Federal Trade Commission (FTC) announced on Tuesday that it has filed a lawsu...

2023-05-17 00:19:41 ET Summary Soros' 13F portfolio value decreased from $7.26B to $6.49B this quarter. The number of positions decreased from 208 to 185. Soros increased Horizon Therapeutics and Splunk while decreasing Rivian, Amazon, Alphabet, and First Horizon. Horizon Ther...